Background and Aims Vibration-controlled transient elastography (VCTE), point shear wave
elastography (pSWE), 2-dimensional shear wave elastography (2DSWE), magnetic …

Background & Aims The enhanced liver fibrosis (ELF) test has been proposed for the non-
invasive assessment of advanced fibrosis in patients with non-alcoholic fatty liver disease …

Abstract Background & Aims Fibrosis is the strongest predictor for long‐term clinical
outcomes among patients with non‐alcoholic fatty liver disease (NAFLD). There is growing …

Background Histologically assessed liver fibrosis stage has prognostic significance in
patients with non-alcoholic fatty liver disease (NAFLD) and is accepted as a surrogate …

Background The reference standard for detecting non-alcoholic steatohepatitis (NASH) and
staging fibrosis—liver biopsy—is invasive and resource intensive. Non-invasive biomarkers …

Background Several reports recommend the implementation of perinatal regionalization for
improvements in maternal and neonatal outcomes, while research evidence on the …

Patients who present near term are delivered by a team of family doctors, midwives and
obstetricians chosen according to the mother's risk factors. It is unlikely that Canada's current …

Introduction Association between elevated cytokeratin 18 (CK-18) levels and hepatocyte
death has made circulating CK-18 a candidate biomarker to differentiate non-alcoholic fatty …

Background & Aims Serum microRNA (miRNA) levels are known to change in non-alcoholic
fatty liver disease (NAFLD) and may serve as useful biomarkers. This study aimed to profile …

We report the case of a 40-year-old female diagnosed with COVID-19 after presenting to our
institution with fever, cough and myalgia for three days. Her nasopharyngeal swab tested …